medigraphic.com

2001, Number 4

<< Back Next >>

Rev Med Hosp Gen Mex 2001; 64 (4)

Hemochromatosis. Review of the literature and presentation of a demonstrative case

León-González MG, Zárate-Sánchez T, Vargas-Trujillo S, Aguilar Martínez E, Martínez-Bistrain A, Palacios-López C, Gutiérrez-Romero M

Language: Spanish
References: 28
Page: 246-250
PDF size: 109.04 Kb.


ABSTRACT

The hemochromatosis concepts are reviewed their causes, frequency and processing. A case appears that initially quick to discussion if it were a primary hemochromatosis non HFE and that finally was secondary to chronic a viral hepatitis C with cirrhosis data. The considerations that in our means are a rare pathology, even the secondary forms, not thus in Saxon and European countries, in where become the primary hemochromatosis HFE it’s consider the genetic upheaval in the more frequent white race (7%) with one prevalence of 1 in 300.


REFERENCES

  1. Adams PC, Valberg LS. Evolving expression of hereditary hemochromatosis. Semin Liver Dis 1996; 16: 47-54.

  2. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Stromeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-1119.

  3. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms and age in 410 patients with hemochromatosis. Hepatology 1997; 25: 162-166.

  4. Burke W, Thomas E, Khoury MJ. Hereditary hemochromatosis, gene discovery and its implications for population-based screening. JAMA 1998; 280: 172-178.

  5. Von Recklinghhausen FD. Uber haemochromatosis. Heidelberg: Taggeblatt (62) Versammling Dtsch Naturforsch Artze; 1889: 324-325.

  6. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998; 129: 925-931.

  7. Sheldon JH. Haemochromatosis. London: Oxford Univ Pr, 1935.

  8. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic hemochromatosis. Gut 1976; 2: 332-334.

  9. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 251-252.

  10. Carella M, D’Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, Girelli D et al. Mutation analysis of the HLA-H gene in Italian Hemochromatosis patients. Am J Hum Genet 1997; 60: 828-832.

  11. Shaheen NJ, Bacon BR, Grimm IS. Clinical characteristic of hereditary hemochromatosis patients who lack the C282Y mutation. Hepatology 1998; 28: 526-529.

  12. Zhou XY, Tomatsu S, Fleming RE et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998; 95: 2492-2497.

  13. Beutler E, Gelbart T, West C et al. Mutation analysis in hereditary hemochromatosis. Blood Cell Mol Dis 1996; 22: 187-914.

  14. Feder JN, Tsuchihashi Z, Irrinki A et al. The hemochromatosis founder mutation in HLA-H disrupts beta-2 microglobulin interaction and cell surface expression. J Biol Chem 1997; 272: 14025-14028.

  15. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds). Iron metabolism in health and disease. Philadelphia: WB Saunders, 1994: 227-70.

  16. Crawford DH, Jazwinska EC, Cullen LM, Powell LM. Expression of HLA-linked hemochromatosis subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998; 114: 1003-1008.

  17. Brittenham GM, Franks AL, Rickles FR. Research priorities in hereditary hemochromatosis. Ann Intern Med 1998; 129: 993-996.

  18. Himmelmann A, Fehr J. Cloning of the hereditary hemochromatosis gene: Implications for pathogenesis, diagnosis, and screening. J Lab Clin Med 1999; 133: 229-236.

  19. Looker AC, Johnson CL. Prevalence of elevated serum transferrin saturation in adults in the United States. Annals of Internal Medicine 1998; 129: 940-945.

  20. Niederau C, Fischer R, Sonnenberg A et al. Survival and causes of death in cirrhotic and in non cirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 1256-1262.

  21. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991; 101: 368-372.

  22. Press RD. Hereditary hemochromatosis: Impact of molecular and iron-based testing on the diagnosis, treatment, and prevention of a common, chronic disease. Arch Pathol Lab Med 1999; 123: 1053-1059.

  23. Heishko C, Weatherall DJ. Iron-chelating therapy. Crit Rev Clin Lab Sci 1988; 26: 303-304.

  24. Gutiérrez RM, Vargas TS. Comunicación personal.

  25. Valdez E, Chávez LG. Diabetes mellitus e hiperpigmentación cutánea generalizada. Rev Fac Med UNAM 1999; 42: 244-249.

  26. Rodríguez A, García GR, Siorda GA, Fernan F, Cantú MA, Tejeda S. Hemocromatosis neonatal. Informe de 3 casos de autopsias. Rev Inv Clin Mex 1999; 51: 81-87.

  27. Seamark C, Hutchinson M. Should asymptomatic haemochromatosis be treated? BMJ 2000; 320: 1314-7.

  28. Olynyk JK. Hereditary haemochromatosis: diagnosis and management in the gene era. Liver 1999; 19: 73-80.




2020     |     www.medigraphic.com